Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 72-76 , 15 May 2010

GABAergic but not anti-cholinergic agents re-induce clinical deficits after stroke

  • Ronald M. Lazar

      Affiliations

    • Stroke Division, Department of Neurology, Columbia University Medical Center, New York, NY, USA
    • Corresponding Author InformationCorresponding author. Department of Neurology, Neurological Institute, 710 West 168th Street, New York, NY 10032, USA. Tel.: +1 212 305 4749; fax: +1 212 305 3741.
    • ,
  • Mitchell F. Berman

      Affiliations

    • Department of Anesthesiology, Columbia University Medical Center, New York, NY, USA
    • ,
  • Joanne R. Festa

      Affiliations

    • Stroke Division, Department of Neurology, Columbia University Medical Center, New York, NY, USA
    • ,
  • Allison E. Geller

      Affiliations

    • Stroke Division, Department of Neurology, Columbia University Medical Center, New York, NY, USA
    • ,
  • Teresa G. Matejovsky

      Affiliations

    • Stroke Division, Department of Neurology, Columbia University Medical Center, New York, NY, USA
    • ,
  • Randolph S. Marshall

      Affiliations

    • Stroke Division, Department of Neurology, Columbia University Medical Center, New York, NY, USA

Received 30 June 2009 ,Revised 26 January 2010 ,Accepted 27 January 2010.

References 

  1. Gresham GE, Phillips TF, Wolf PA, McNamara PM, Kannel WB, Dawber TR. Epidemiologic profile of long-term stroke disability: the Framingham study. Arch Phys Med Rehabil. Nov 1979;60(11):487–491
  2. Marshall RS, Perera GM, Lazar RM, Krakauer JW, Constantine RC, DeLaPaz RL. Evolution of cortical activation during recovery from corticospinal tract infarction. Stroke. Mar 2000;31(3):656–661
  3. Floel A, Cohen LG. Recovery of function in humans: cortical stimulation and pharmacological treatments after stroke. Neurobiol Dis. 2010;47(3):243–251
  4. Ward NS, Frackowiak RS. The functional anatomy of cerebral reorganisation after focal brain injury. J Physiol Paris. Jun 2006;99(4–6):425–436
  5. Saur D, Lange R, Baumgaertner A, Schraknepper V, Willmes K, Rijntjes M, et al. Dynamics of language reorganization after stroke. Brain. Jun 2006;129(Pt 6):1371–1384
  6. Cramer SC. Use of imaging in restorative stroke trials. Stroke. Mar 2009;40(3 Suppl):S28–S29
  7. Johansen-Berg H. Functional imaging of stroke recovery: what have we learnt and where do we go from here?. Int J Stroke. Feb 2007;2(1):7–16
  8. Alonso-Alonso M, Fregni F, Pascual-Leone A. Brain stimulation in poststroke rehabilitation. Cerebrovasc Dis. 2007;24(Suppl 1):157–166
  9. Rossini PM, Altamura C, Ferreri F, Melgari JM, Tecchio F, Tombini M, et al. Neuroimaging experimental studies on brain plasticity in recovery from stroke. Eura Medicophys. Jun 2007;43(2):241–254
  10. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. Aug 27 1982;217(4562):855–857
  11. Hurwitz BE, Dietrich WD, McCabe PM, Alonso O, Watson BD, Ginsberg MD. Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex. Stroke. May 1991;22(5):648–654
  12. Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with d-amphetamine therapy after neocortical infarction in. Stroke. Nov 1998;29(11):
  13. Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. Jan 1988;23(1):94–97
  14. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke. Dec 1995;26(12):2254–2259
  15. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil. Sep 1998;79(9):1047–1050
  16. Walker-Batson D, Curtis S, Natarajan R, Ford J, Dronkers N, Salmeron E, et al. A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke. Sep 2001;32(9):2093–2098
  17. Goldstein LB. Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology. Mar 3 2000;39(5):852–859
  18. Windle V, Corbett D. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain Res. May 17 2005;1044(1):25–32
  19. Floel A, Hummel F, Breitenstein C, Knecht S, Cohen LG. Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology. Aug 9 2005;65(3):472–474
  20. Berthier ML, Green C, Higueras C, Fernandez I, Hinojosa J, Martin MC. A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology. Nov 14 2006;67(9):1687–1689
  21. Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol. Apr 1998;55(4):454–456
  22. Gladstone DJ, Black SE. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?. Can J Neurol Sci. May 2000;27(2):97–105
  23. Lazar RM, Fitzsimmons BF, Marshall RS, Berman MF, Bustillo MA, Young WL, et al. Reemergence of stroke deficits with midazolam challenge. Stroke. Jan 2002;33(1):283–285
  24. Lazar RM, Fitzsimmons BF, Marshall RS, Mohr JP, Berman MF. Midazolam challenge reinduces neurological deficits after transient ischemic attack. Stroke. Mar 2003;34(3):794–796
  25. Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit. Oct 2005;27(5):655–665
  26. Meintzschel F, Ziemann U. Modification of practice-dependent plasticity in human motor cortex by neuromodulators. Cereb Cortex. Aug 2006;16(8):1106–1115
  27. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron. Sep 30 2004;44(1):5–21
  28. Nadeau SE, Behrman AL, Davis SE, Reid K, Wu SS, Stidham BS, et al. Donepezil as an adjuvant to constraint-induced therapy for upper-limb dysfunction after stroke: an exploratory randomized clinical trial. J Rehabil Res Dev. Jul 2004;41(4):525–534
  29. Mathiowetz V, Weber K, Kashman N, Volland G. Adult norms for the nine hole peg test of finger dexterity. Occup Ther J Res. 1985;5:24–38
  30. Small SL, Hlustik P, Noll DC, Genovese C, Solodkin A. Cerebellar hemispheric activation ipsilateral to the paretic hand correlates with functional recovery after stroke. Brain. Jul 2002;125(Pt 7):1544–1557
  31. Lazar RM, Speizer AE, Festa JR, Krakauer JW, Marshall RS. Variability in language recovery after first-time stroke. J Neurol Neurosurg Psychiatry. May 2008;79(5):530–534
  32. Kertesz A. Western aphasia battery—revised. San Antonio, TX: Harcourt Assessment; 2006;
  33. Goodglass H, Kaplan E. Boston diagnostic aphasia examination. Philadelphia: Lea and Febiger; 1983;
  34. Lansing AE, Ivnik RJ, Cullum CM, Randolph C. An empirically derived short form of the Boston naming test. Arch Clin Neuropsychol. Aug 1999;14(6):481–487
  35. Neves G, Cooke SF, Bliss TV. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci. Jan 2008;9(1):65–75
  36. Gaiarsa JL, Caillard O, Ben-Ari Y. Long-term plasticity at GABAergic and glycinergic synapses: mechanisms and functional significance. Trends Neurosci. Nov 2002;25(11):564–570
  37. Carmichael ST. Plasticity of cortical projections after stroke. Neuroscientist. Feb 2003;9(1):64–75
  38. Malenka RC, Nicoll RA. Long-term potentiation—a decade of progress?. Science. Sep 17 1999;285(5435):1870–1874
  39. Hagemann G, Redecker C, Neumann-Haefelin T, Freund HJ, Witte OW. Increased long-term potentiation in the surround of experimentally induced focal cortical infarction. Ann Neurol. Aug 1998;44(2):255–258
  40. Que M, Witte OW, Neumann-Haefelin T, Schiene K, Schroeter M, Zilles K. Changes in GABA(A) and GABA(B) receptor binding following cortical photothrombosis: a quantitative receptor autoradiographic study. Neuroscience. 1999;93(4):1233–1240
  41. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res. Jul 30 1986;379(1):104–111
  42. Martin JH, Ghez C. Pharmacological inactivation in the analysis of the central control of movement. J Neurosci Methods. Jan 1999;86(2):145–159
  43. Matsumura M, Sawaguchi T, Kubota K. GABAergic inhibition of neuronal activity in the primate motor and premotor cortex during voluntary movement. J Neurophysiol. Sep 1992;68(3):692–702
  44. Wada JA. Clinical experimental observations of carotid artery injections of sodium amytal. Brain Cogn. Feb 1997;33(1):11–13
  45. Lazar RM, Marshall RS, Pile-Spellman J, Hacein-Bey L, Young WL, Mohr JP, et al. Anterior translocation of language in patients with left cerebral arteriovenous malformation. Neurology. Sep 1997;49(3):802–808
  46. Butefisch CM, Davis BC, Wise SP, Sawaki L, Kopylev L, Classen J, et al. Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sci U S A. Mar 28 2000;97(7):3661–3665
  47. Di Piero V, Di Legge S, Altieri M, Lenzi GL. When is a stroke actually “stable”?. Stroke. 2002 (Jun);33(6):1456–1457discussion-7
  48. Tapp PD, Chu Y, Araujo JA, Chiou JY, Head E, Milgram NW, et al. Effects of scopolamine challenge on regional cerebral blood volume. A pharmacological model to validate the use of contrast enhanced magnetic resonance imaging to assess cerebral blood volume in a canine model of aging. Prog Neuropsychopharmacol Biol Psychiatry. Mar 2005;29(3):399–406
  49. Tsukada H, Kakiuchi T, Ando I, Ouchi Y. Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys. J Pharmacol Exp Ther. Jun 1997;281(3):1408–1414
  50. Honer WG, Prohovnik I, Smith G, Lucas LR. Scopolamine reduces frontal cortex perfusion. J Cereb Blood Flow Metab. Oct 1988;8(5):635–641
  51. Gitelman DR, Prohovnik I. Muscarinic and nicotinic contributions to cognitive function and cortical blood flow. Neurobiol Aging. Mar–Apr 1992;13(2):313–318

PII: S0022-510X(10)00054-7

doi: 10.1016/j.jns.2010.01.024

Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 72-76 , 15 May 2010

Article Tools

* Image Usage & Resolution